Healthcare - Biotechnology - NASDAQ - US
$ 5.08
-8.96 %
$ 750 M
Market Cap
-3.79
P/E
INCOME STATEMENT
170 M
REVENUE
-227 M
OPERATING INCOME
-225 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Adaptive Biotechnologies Corporation
| Revenue | 170 M |
| Cost Of Revenue | 75.6 M |
| Gross Profit | 94.7 M |
| Operating Expenses | 322 M |
| Operating Income | -227 M |
| Other Expenses | -1.78 M |
| Net Income | -225 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 170.3 | 185.3 | 154.3 | 98.4 | 85.1 | 55.7 | 38.4 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 75.6 | 57.9 | 49.3 | 22.5 | 22.3 | 19.7 | 15.7 |
| Gross Profit | 94.7 | 127.4 | 105.0 | 75.9 | 62.8 | 36.0 | 22.8 |
| OPERATING INCOME | |||||||
| Operating Expenses | 321.8 | 327.6 | 314.0 | 228.7 | 141.2 | 85.8 | 66.4 |
| Selling, General and Administrative Expenses | 172.5 | 184.1 | 170.0 | 110.9 | 68.8 | 44.9 | 32.7 |
| Research and Development Expenses | 122.1 | 141.8 | 142.3 | 116.1 | 70.7 | 39.2 | 32.0 |
| Operating Income | (227.0) | (200.2) | (209.0) | (152.8) | (78.4) | (49.8) | (44.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 13.8 | 4.2 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 1.7 | (0.2) | 1.7 | 6.6 | 9.8 | 3.3 | 1.6 |
| Pre-Tax Income | (225.3) | (200.4) | (207.3) | (146.2) | (68.6) | (46.4) | (42.8) |
| NET INCOME | |||||||
| Tax Provision | 0 | (57.9) | (1.7) | (6.6) | (9.8) | 3.3 | (0.8) |
| Net Income | (225.2) | (142.5) | (205.6) | (139.6) | (58.8) | (46.4) | (42.8) |
| EPS | 1.56 | 1 | 1.46 | 1.06 | 0.85 | 0.44 | 0.41 |